文献速递前列腺增生与排尿功能障碍

水蒸气热疗后下尿路症状的再次治疗

Retreatment for Lower Urinary Tract Symptoms After Water Vapor Thermal Therapy.
PubMed 文献 · Urology · 2024-04-25

回顾性分析单中心2017年8月至2022年2月接受水蒸气热疗(WVTT)的192例患者,10例(5%)在2年内因症状持续或复发再次手术。再次治疗组前列腺体积更小、水蒸气注射次数更多,术后6个月IPSS总分和排尿症状评分更差。多因素分析显示每叶注射超过1次与再次治疗风险独立相关(HR 8.509)。

要点

  • WVTT再次治疗率为5%(10/192)。
  • 再次治疗组每叶水蒸气注射次数更多(4.4±1.8 vs 5.2±3.9,P<.001)。
  • 每叶注射超过1次与再次治疗风险独立相关(HR 8.509,95%CI 1.109-65.293,P=.039)。

核心结论

  • WVTT再次治疗率低;需要再次治疗的男性接受了更多注射,且术后6个月排尿症状评分更差;减少注射次数可能有助于降低治疗失败率。

研究设计与样本

  • 回顾性综述单中心2017年8月至2022年2月接受WVTT的患者,共192例,比较2年内因持续或复发下尿路症状接受第二次BPH手术的患者与未再次治疗的患者,采用多因素分析评估再次治疗的预测因素。

主要发现

  • 192例中10例(5%)接受再次治疗。
  • 再次治疗组前列腺体积更小(50.4±18.2 cc vs 48.5±35.7 cc,P=.003)。
  • 再次治疗组接受的水蒸气注射次数更多(4.4±1.8 vs 5.2±3.9,P<.001)。
  • 术后6个月随访,再次治疗组IPSS总分更差(10.13±7.40 vs 18.5±11.55,P=.044),排尿症状评分也更差(4.59±4.39 vs 9.5±7.84,P=.006)。
  • 多因素分析显示,每叶注射超过1次与再次治疗风险增加独立相关(HR 8.509,95%CI 1.109-65.293,P=.039)。

临床怎么用

  • 作者认为减少注射次数可能有助于降低治疗失败率。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To identify predictors of retreatment for symptomatic recurrence among men who undergo water vapor thermal therapy (WVTT; Rezum, Boston Scientific, Marlborough, MA), a minimally invasive surgical treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. METHODS: We retrospectively reviewed patients treated with WVTT at a single institution from August 2017 to February 2022. Patients who underwent a second benign prostatic hyperplasia procedure for persistent or recurrent lower urinary tract symptoms within 2years of original treatment were compared to the remaining cohort who did not undergo retreatment. Multivariate analysis was used to assess for predictors of retreatment. RESULTS: Data were obtained from 192 patients. 10 (5%) patients were retreated. The retreatment cohort had smaller prostate volumes (50.4±18.2 cc vs 48.5±35.7 cc; P = .003) and received a greater number of water vapor injections (4.4±1.8 vs 5.2±3.9; P < .001). At 6month follow-up, total International Prostate Symptom Score (IPSS; 10.13 ± 7.40 vs 18.5 ± 11.55, P = .044) and voiding subscores (4.59 ± 4.39 vs 9.5 ± 7.84, P = .006) were significantly worse in the retreatment group. On multivariate analysis, >1 treatment per lobe was independently associated with increased risk of retreatment (hazard ratio 8.509, 95% CI [1.109-65.293]; P = .039). CONCLUSION: WVTT has a low retreatment rate. Men who required retreatment received more injections and showed worsened voiding symptom scores 6months postoperatively. Decreasing the number of injections may help reduce treatment failure rates.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Nguyen V, Leach MC, Cerrato C, et al. Retreatment for Lower Urinary Tract Symptoms After Water Vapor Thermal Therapy. Urology. 2024. PMID: 38677371. doi:10.1016/j.urology.2024.04.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。